T11408 |
GLP-1 receptor agonist 1
|
2212020-52-3
|
98%
|
|
GLP-1 receptor agonist 1 is a GLP-1 receptor agonist .
|
T7364 |
NNC-0640
|
307986-98-7
|
98%
|
|
NNC-0640 is a negative allosteric modulator of Human Glucagon Receptor with an IC50 of 69.2 nM.
|
T12878 |
Semaglutide TFA (910463-68-2 free base)
|
T12878
|
98%
|
|
Semaglutide TFA is a agonist of glucagon-like peptide-1 (GLP-1) receptor,with a potential for type 2 diabetes treatment.
|
T14130 |
Adomeglivant
|
1488363-78-5
|
98%
|
|
Adomeglivant is a potent and selective glucagon receptor antagonist. Which is used in clinical trial for type 2 diabetes mellitus.
|
TP1452L1 |
HAEGTFTSD acetate(926018-45-3 free base)
|
TP1452L1
|
98%
|
|
HAEGTFTSD acetate is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from in...
|
T11845 |
LGD-6972
|
1207989-09-0
|
98%
|
|
LGD-6972 is an antagonist of glucagon receptor.
|
T35337 |
Teduglutide
|
197922-42-2
|
98%
|
|
|
T37890L |
GLP-1(28-36)amide acetate
|
T37890L
|
98%
|
|
GLP-1(28-36)amide acetate inhibits mitochondrial permeability transition with antioxidant, anti-diabetic and cardioprotection activities.
|
T35337L |
Teduglutide acetate
|
|
98%
|
|
Teduglutide acetate, a GLP-2 analogue, maximizes small intestinal mucosal hypertrophy. Teduglutide acetate partially restores small intestinal epithelial functio...
|
TP2071L |
Bay 55-9837 acetate
|
|
98%
|
|
Bay 55-9837 acetate is a potent and highly selective VPAC2 agonist(Kd = 0.65 nM) and can be used in type 2 diabetes studies.
|
TP1039 |
Secretin (33-59), rat
|
121028-49-7
|
98%
|
|
Secretin (33-59), rat is a 27-aa peptide, acts on secretin receptor, enhances the secretion of bicarbonate, enzymes, and K+ from the pancreas.
|
T36579 |
GLP-1R Agonist DMB
|
281209-71-0
|
98%
|
|
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor).
|
T9579L |
GLP-1 receptor agonist 9 citrate
|
T9579L
|
98%
|
|
GLP-1 receptor agonist 9 citrate is an agonist of GLP-1.
|
TP1863L |
Glucagon (19-29), human acetate
|
TP1863L
|
98%
|
|
Glucagon (19-29), human acetate a COOH-terminal fragment processed from glucagon, is a potent and efficient inhibitor of insulin secretion.
|
T22893 |
L-168049
|
191034-25-0
|
100%
|
|
L-168049 is a selective and non-competitive antagonist of human glucagon receptor with IC50s of 3.7 nM, 63 nM, and 60 nM for human, murine, and canine, respectiv...
|
TP1419L |
HAEGTFT acetate(926018-95-3 free base)
|
TP1419L
|
100%
|
|
HAEGTFT acetate is the first N-terminal 1-7 residues of GLP-1 peptide.
|
TP1796 |
Albiglutide TFA (782500-75-8 free base)
|
TP1796
|
100%
|
|
Albiglutide TFA is a long acting GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus (T2DM).
|
TP1111L |
Tirzepatide Acetate(2023788-19-2 free base)
|
TP1111L
|
97.3%
|
|
Tirzepatide acetate is a dual GIP / GLP-1 receptor agonist.
|
TP1382L |
HAEGTFTSDVS acetate
|
TP1382L
|
97.47%
|
|
HAEGTFTSDVS acetate is the first N-terminal 1-11 residues of GLP-1 which stimulates insulin secretion from pancreatic β-cells.
|
TQ0124 |
BETP
|
1371569-69-5
|
97.92%
|
|
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor).
|